Physician profile
Jack Yuan
NPI 1770071128
$1,285.32
in general payments reported to CMS, 2019-2025
14 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.19 · 2020: $160 · 2021: $97.78 · 2022: $157 · 2023: $368 · 2024: $340 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $310.45 | 2022-2024 | Tirosint, Licart, Licart |
| Advanced Oxygen Therapy INC. | $229.47 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $147.42 | 2020-2024 | Collagenase Santyl |
| Kci USA, INC. | $145.80 | 2020 | |
| Paratek Pharmaceuticals, INC. | $113.95 | 2021-2024 | Nuzyra |
| Horizon Therapeutics Plc | $84.20 | 2021-2023 | Krystexxa |
| Integra Lifesciences Corporation | $47.20 | 2019 | |
| Nevro Corp. | $47.13 | 2021-2022 | |
| Treace Medical Concepts, INC. | $41.35 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $33.84 | 2023 | Seglentis |
| Bioventus LLC | $28.92 | 2024 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $23.12 | 2024 | Qutenza |
| Organogenesis INC. | $17.48 | 2023 | Puraply |
| Allergan, INC. | $14.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Yuan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.